###begin article-title 0
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Ass, and Alzheimer's Disease
###end article-title 0
###begin p 1
Conceived and designed the experiments: MMC OB FZ MA LHY AW SGY KM. Performed the experiments: MMC OB FZ MA MA SLW MRK LM LHY TAD MEH CCH CMS CMW MC VV CH KB. Analyzed the data: MMC OB FZ MA NET MA SLW MRK SGY CSY VV CH VSP SGY KM. Contributed reagents/materials/analysis tools: MMC NH IR HC OP PP DC BM ST PGK DM ADS HB DW CH RH HK NK DWD NRGR RCP SGY KM. Wrote the paper: MMC OB FZ MA NET SGY KM. Principal investigator: SGY KM.
###end p 1
###begin p 2
Current address: Gen-info Ltd., Zagreb, Croatia
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
The insulin-degrading enzyme gene (IDE) is a strong functional and positional candidate for late onset Alzheimer's disease (LOAD).
###end p 4
###begin title 5
Methodology/Principal Findings
###end title 5
###begin p 6
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 275 278 275 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 441 443 441 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 578 586 578 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1182 1185 1175 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
We examined conserved regions of IDE and its 10 kb flanks in 269 AD cases and 252 controls thereby identifying 17 putative functional polymorphisms. These variants formed eleven haplotypes that were tagged with ten variants. Four of these showed significant association with IDE transcript levels in samples from 194 LOAD cerebella. The strongest, rs6583817, which has not previously been reported, showed unequivocal association (p = 1.5x10-8, fold-increase = 2.12,); the eleven haplotypes were also significantly associated with transcript levels (global p = 0.003). Using an in vitro dual luciferase reporter assay, we found that rs6583817 increases reporter gene expression in Be(2)-C (p = 0.006) and HepG2 (p = 0.02) cell lines. Furthermore, using data from a recent genome-wide association study of two Croatian isolated populations (n = 1,879), we identified a proxy for rs6583817 that associated significantly with decreased plasma Abeta40 levels (ss = -0.124, p = 0.011) and total measured plasma Abeta levels (b = -0.130, p = 0.009). Finally, rs6583817 was associated with decreased risk of LOAD in 3,891 AD cases and 3,605 controls. (OR = 0.87, p = 0.03), and the eleven IDE haplotypes (global p = 0.02) also showed significant association.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 78 81 78 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 211 214 210 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Thus, a previously unreported variant unequivocally associated with increased IDE expression was also associated with reduced plasma Ass40 and decreased LOAD susceptibility. Genetic association between LOAD and IDE has been difficult to replicate. Our findings suggest that targeted testing of expression SNPs (eSNPs) strongly associated with altered transcript levels in autopsy brain samples may be a powerful way to identify genetic associations with LOAD that would otherwise be difficult to detect.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 415 418 413 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Walsh1">[1]</xref>
###xml 437 440 435 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APP</italic>
###xml 442 447 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSEN1</italic>
###xml 453 458 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSEN2</italic>
###xml 581 584 578 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Bertram1">[2]</xref>
###xml 722 725 719 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Gatz1">[3]</xref>
###xml 727 730 724 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Bergem1">[4]</xref>
###xml 736 740 733 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 940 943 919 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Corder1">[5]</xref>
###xml 944 947 923 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Farrer1">[7]</xref>
###xml 1136 1141 1115 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SORL1</italic>
###xml 1141 1144 1120 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Rogaeva1">[8]</xref>
###xml 1146 1150 1125 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAB2</italic>
###xml 1150 1153 1129 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Reiman1">[9]</xref>
###xml 1155 1162 1134 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH11X</italic>
###xml 1162 1166 1141 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Carrasquillo1">[10]</xref>
###xml 1168 1174 1147 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PICALM</italic>
###xml 1174 1178 1153 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Harold1">[11]</xref>
###xml 1180 1183 1159 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU</italic>
###xml 1183 1187 1162 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Harold1">[11]</xref>
###xml 1189 1193 1168 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Lambert1">[12]</xref>
###xml 1198 1201 1177 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CR1</italic>
###xml 1201 1205 1180 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Harold1">[11]</xref>
###xml 1207 1211 1186 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Lambert1">[12]</xref>
###xml 1370 1373 1349 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Late onset Alzheimer's disease (LOAD) is the most common cause of dementia in the elderly affecting approximately 10% of those over the age of 65 years. LOAD is a neurodegenerative condition in which the brain develops large numbers of extracellular senile plaques composed primarily of aggregated amyloid-ss proteins (Ass) as well as intraneuronal neurofibrillary tangles composed mainly of aggregated tau protein [1]. Mutations in the APP, PSEN1, and PSEN2 genes that increase production of Ass are known causes of the rare, early onset, familial form of AD (for review see ref. [2]). Twin studies indicate that genetic factors are also important in late onset AD and account for at least 60% of its phenotypic variance [3], [4]. The APOE epsilon4 allele, which is present in approximately50% of AD cases, is associated with a substantial increase in the risk of LOAD, but it is neither necessary nor sufficient for the development of AD [5]-[7]. Despite an intense search in the past decade, identification of the additional genes that contribute to phenotypic variance in LOAD has proven difficult. Promising new LOAD genes such as SORL1[8], GAB2[9], PCDH11X[10], PICALM[11], CLU[11], [12] and CR1[11], [12] are, however, now being identified through genome-wide association studies and follow-up analyses in large case-control series. Here, we evaluate variants in IDE for association with LOAD and with two additional endophenotypes that have important functional implications.
###end p 10
###begin p 11
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 132 136 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Kurochkin1">[13]</xref>
###xml 137 141 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Farris1">[17]</xref>
###xml 176 183 174 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 183 187 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Farris2">[18]</xref>
###xml 188 192 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Miller1">[20]</xref>
###xml 194 197 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 310 313 308 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 469 473 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Blacker1">[21]</xref>
###xml 475 479 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Kehoe1">[22]</xref>
###xml 530 534 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Bertram2">[23]</xref>
###xml 628 631 626 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 742 746 740 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-AitGhezala1">[24]</xref>
###xml 827 830 825 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 957 961 955 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Prince1">[25]</xref>
###xml 1020 1024 1018 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-ErtekinTaner1">[26]</xref>
###xml 1255 1258 1250 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 1392 1396 1384 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Blomqvist1">[27]</xref>
IDE is a strong functional LOAD candidate gene because it encodes the insulin degrading enzyme, which has been shown to degrade Ass [13]-[17] and to influence brain Ass levels in vivo[18]-[20]. IDE has also obtained much attention as an LOAD candidate gene because of its location near LOAD linkage peaks. The IDE gene is located on chromosome 10q23.33, very near a 'suggestive' linkage peak (chromosome 10q24) found in two genome-wide linkage studies of LOAD families [21], [22] and a 'significant' linkage peak (10q) in a third [23]. The latter study showed allele-specific association of a variant (D10S583) within 195 kb of IDE with LOAD, an association that was confirmed by independent follow-up analysis in an LOAD case-control series [24]. Independent haplotype analysis by Prince et al. of a 276-kb block encompassing IDE showed highly significant association with LOAD and with several intermediate LOAD phenotypes in multiple case-control series [25]. When we performed follow-up analysis on these haplotypes [26], we found highly significant association with LOAD in one case-control series and significant association with plasma Abeta42 levels in extended LOAD families. These findings were supported by an independent study that associated IDE variants with Abeta plaque density and cognitive function in three independent Swedish LOAD series and in a follow-up English series [27], although the variants were not directly associated with disease risk.
###end p 11
###begin p 12
###xml 5 8 5 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Blomqvist1">[27]</xref>
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Ozturk1">[38]</xref>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Sakai1">[39]</xref>
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Bian1">[40]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Bjork1">[29]</xref>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Blomqvist2">[30]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Edland1">[33]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Edland2">[34]</xref>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Mueller1">[36]</xref>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Bian1">[40]</xref>
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Blomqvist1">[27]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Abraham1">[28]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Boussaha1">[31]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Cellini1">[32]</xref>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Feuk1">[35]</xref>
###xml 364 368 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Nowotny1">[37]</xref>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Sakai1">[39]</xref>
###xml 450 453 450 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Many IDE variants, including those studied by Prince et al. and by our group, have been analyzed in additional follow-up studies of Caucasian [27]-[38], Japanese [39], and Han Chinese [40] case-control series. Some of these studies showed significant evidence for association [29], [30], [33], [34], [36], [40] whereas others did not [27], [28], [31], [32], [35], [37]-[39]. AlzGene () meta-analysis of 12 variants from 21 publications investigating IDE to date shows no significant association.
###end p 12
###begin p 13
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Bertram3">[41]</xref>
Overall, studies of IDE variants provide evidence for association with LOAD that is difficult to dismiss as a set of false positives, but the association is not compelling because replication is inconsistent and the results of meta-analyses do not achieve significance [41].
###end p 13
###begin title 14
Results
###end title 14
###begin p 15
###xml 128 131 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 543 551 541 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s003">Table S1</xref>
###xml 543 551 541 549 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s003">Table S1</xref></bold>
###xml 660 668 658 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s004">Table S2</xref>
###xml 660 668 658 666 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s004">Table S2</xref></bold>
###xml 673 682 671 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s002">Figure S1</xref>
###xml 673 682 671 680 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s002">Figure S1</xref></bold>
###xml 769 772 767 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 886 890 <span type="species:ncbi:162683">Mayo</span>
Using dHPLC followed by sequencing, we screened conserved regions (>/=70% identity identity in human vs rodent sequence) in the IDE gene and in 10 kb of 5' and 3' flanking sequence for variants likely to be functional. In each of the 521 subjects screened (269 cases and 252 controls), we evaluated 40 amplicons that contained a total of 9,501 bp of conserved DNA. This DNA included all exons (5,954 bp), conserved regions in the 5' (268 bp) and 3' (1,465 bp) flanking regions, and 1,814 bp of highly conserved intronic sequence. This search (Table S1 online) yielded 17 common polymorphisms (minor allele frequencies >0.01) likely to have functional effects (Table S2 and Figure S1 online). These variants and the haplotypes they form were tested for association with IDE mRNA expression using transcript levels measured in 194 LOAD cerebella sampled at autopsy from the brain bank at Mayo Clinic, Jacksonville. They were also analyzed for genetic association with LOAD in one of the largest LOAD case-control series studied to date, which consisted of 3,529 AD cases and 3,441 controls drawn from four American and five North European series.
###end p 15
###begin p 16
###xml 7 10 7 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 106 115 106 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s005">Tables S3</xref>
###xml 106 115 106 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s005">Tables S3</xref></bold>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s006">S4</xref>
###xml 120 122 120 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s006">S4</xref></bold>
###xml 174 181 174 181 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 174 181 174 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008764-t001"><bold>Table 1</bold></xref>
###xml 218 221 218 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 375 378 375 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 391 398 391 398 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 391 398 391 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008764-t002"><bold>Table 2</bold></xref>
###xml 497 499 497 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 607 610 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 1088 1104 1088 1104 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A and 1B</bold>
###xml 1088 1104 1088 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008764-g001"><bold>Figure 1A and 1B</bold></xref>
###xml 1106 1115 1106 1115 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 1106 1115 1106 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008764-g001"><bold>Figure 1C</bold></xref>
###xml 1168 1171 1168 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
The 17 IDE variants formed eleven haplotypes with frequencies >1% that could be tagged with ten variants (Tables S3 and S4 online). In the combined series, these haplotypes (Table 1) were significantly associated with IDE transcript levels (global p = 0.003) and with LOAD (global p = 0.02). Of the ten tagging variants, four showed significant association with the level of IDE transcript (Table 2). Association was most significant for v311 (rs6583817) and v3 (rs5786996) with p-values of 1.5x10-8 and 0.0005 respectively, and linear regression showed that for both of these variants the average level of IDE transcript was more than 2-fold higher for each minor allele carried. In the combined series, the minor alleles of v311 (p = 0.03) and v3 (p = 0.02) were also associated with reduced risk of LOAD. Notably, neither variant has previously been analyzed for association with LOAD, so they are not included in the AlzGene database. The association of these two variants with LOAD showed no series-related effects. Results for each of the eight series that were tested are shown in Figure 1A and 1B. Figure 1C shows box plots which compare the relative level of IDE transcript in carriers of these two variants as compared to non-carriers.
###end p 16
###begin title 17
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Association of variants 3 (rs5786996) and 311 (rs6583817) with LOAD and IDE mRNA levels.
###end title 17
###begin p 18
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 541 545 535 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 584 585 572 573 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 666 667 654 655 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 706 709 694 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 798 801 786 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 827 840 815 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 1190 1193 1170 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 1294 1298 1270 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
(A) Variants were analyzed for association with LOAD using an additive logistic regression model with age at diagnosis/entry, sex and APOE epsilon4 dosage as covariates. N; total genotype count, MAF; minor allele frequency. For logistic regression of the combined series, individual series were included as covariates. P values demonstrating that there were no series-related effects on association (p*) were obtained by comparing this model to one that adjusts for series x genotype interactions in addition to age at diagnosis/entry, sex, APOE epsilon4 dosage, and series effects. (B) OR and 95% CI forest plots were generated from the data tabulated in panel a. (C) Association of the two variants with IDE mRNA levels in cerebellum. The horizontal black line and dots represent median relative IDE mRNA level expressed as 2-DeltaDeltaCt for each variant. Boxes represent the 25th and 75th percentiles and whiskers represent the full data range.11 = homozygotes for the major allele, 12 = heterozygotes, 22 = minor allele homozygotes. Samples with 12 and 22 genotypes for rs6583817 were combined because only two samples were 22. Variants were analyzed for association with the level of IDE transcript (DeltaCT) using an additive linear regression model with age at diagnosis/entry, sex and APOE epsilon4 dosage as covariates.
###end p 18
###begin title 19
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Association of IDE common conserved haplotypes with cerebellar IDE mRNA and LOAD.
###end title 19
###begin p 20
###xml 464 467 464 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 533 537 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 675 682 666 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;&#946;)</sup>
###xml 743 758 731 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">[&#8722;(&#946;&#177;SEM)]</sup>
###xml 876 880 859 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
Haplotypes are numbered according to their frequency. Only haplotypes with frequency >0.01 are shown. The "Haplotype" and "Variant ID" columns show the allelic composition of each haplotype in the 5' to 3' orientation from the p to the q telomere of chromosome 10. The allelic composition of each haplotype is depicted as "0" for no minor allele and "1" for minor allele. Freq = haplotype frequency in the combined series. Haplotype linear regression analyses vs. IDE mRNA levels were performed using an additive model adjusting for APOE epsilon4 dosage, age at diagnosis/entry and sex. beta = regression coefficient. Fold difference in expression is derived from the term (2(-beta)). 95% confidence intervals (CI) were derived from the term 2[-(beta+/-SEM)]; p = p value. Haplotype logistic regression analyses vs. LOAD were carried out using an additive model adjusting for APOE epsilon4 dosage, age at diagnosis/entry, sex and series. OR = odds ratio.
###end p 20
###begin title 21
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Association of IDE common conserved variants with cerebellar IDE mRNA and LOAD.
###end title 21
###begin p 22
###xml 464 467 462 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 533 537 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 716 723 705 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;&#946;)</sup>
###xml 784 799 770 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">[&#8722;(&#946;&#177;SEM)]</sup>
###xml 922 926 903 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 141 146 <span type="species:ncbi:9606">Human</span>
###xml 215 220 <span type="species:ncbi:9606">human</span>
###xml 225 230 <span type="species:ncbi:10090">mouse</span>
Variant IDs and rs numbers (dbSNP variant identifier) are given for the 10 tagging variants; Chr position indicates relative position to the Human Genome build 36.1. Cons = conservation (>/=70% identity between the human and mouse sequence); MAF = minor allele frequency in controls; HWE-p = Hardy-Weinberg Equilibrium p value in controls; columns labeled as 1 and 2 indicate the major and minor allele, respectively. Single variant linear regression analyses vs. IDE mRNA levels were performed using an additive model adjusting for APOE epsilon4 dosage, age at diagnosis/entry and sex. beta = regression coefficient. Fold difference in expression due to a single copy of the minor allele is derived from the term (2(-beta)). 95% confidence intervals (CI) were derived from the term 2[-(beta+/-SEM)]; p = p value. Single variant logistic regression analyses vs. LOAD were carried out using an additive model adjusting for APOE epsilon4 dosage, age at diagnosis/entry, sex and series. OR = odds ratio.
###end p 22
###begin p 23
###xml 88 95 88 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 88 95 88 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008764-t001"><bold>Table 1</bold></xref>
###xml 100 108 100 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</bold>
###xml 100 108 100 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008764-g001"><bold>Figure 1</bold></xref>
###xml 128 135 128 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s001">Text S1</xref>
###xml 128 135 128 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s001">Text S1</xref></bold>
###xml 266 269 266 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Additional discussion of the complex single variant and haplotype associations shown in Table 1 and Figure 1 is provided in the Text S1 online. There, we consider two contrasting models; a simple model where v311 is postulated to be the only variant that influences IDE function and a more complex model where multiple haplotypes would have independent effects. We emphasize that the current study has inadequate power to distinguish between these models.
###end p 23
###begin p 24
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 92 95 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 403 407 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Vitart1">[42]</xref>
###xml 408 412 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Zemunik1">[44]</xref>
We further explored the involvement of IDE in LOAD pathogenesis by evaluating the effect of IDE on Ass levels. To this end, we analyzed plasma Ass40, Ass42 and total Ass (Ass40 +Ass42) in 949 individuals from Vis and 930 individuals from Korcula (total = 1,879), which are two isolated populations from the Dalmatian islands recently analyzed for multiple disease related traits using genome-wide scans [42]-[44].
###end p 24
###begin p 25
###xml 201 209 201 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s007">Table S5</xref>
###xml 201 209 201 209 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s007">Table S5</xref></bold>
###xml 647 655 627 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s007">Table S5</xref>
###xml 647 655 627 635 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s007">Table S5</xref></bold>
###xml 1172 1175 1132 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Our analysis took advantage of the strong linkage disequilibrium between v311 and rs7910977 (r2 = 0.996 and D' = 1), since rs7910977, but not v311, was included in the genome-wide scan. This analysis (Table S5 online) showed that rs7910977 was significantly associated with reduced levels of plasma Ass40 in the Vis population (ss +/- SE = -0.147+/-0.06 p = 0.018) and suggestively associated with reduced Abeta40 in the Korcula population (ss +/- SE = -0.086+/-0.08, p = 0.27). Meta-analysis of the two populations showed overall significant association with reduced Ass40 (ss +/- SE = -0.124+/-0.05, p = 0.011). Analysis of the two populations (Table S5 online) also showed a suggestive association between rs7910977 and reduced plasma Ass42 levels (meta-analysis ss +/- SE = -0.07+/-0.05, p = 0.18). Similarly, analysis of total Ass (Ass40 +Ass42) revealed significant association with reduced levels in the Vis population (ss +/- SE = -0.165+/-0.06, p = 0.011) and meta-analysis of the two populations showed overall significant association with reduced total Ass (ss +/- SE = -0.130+/-0.05, p = 0.009) Thus the variant that showed strongest association with elevated IDE expression also showed significant association with reduced levels of Ass, a substrate of the insulin degrading enzyme that is implicated in LOAD pathogenesis.
###end p 25
###begin p 26
###xml 30 37 30 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s001">Text S1</xref>
###xml 30 37 30 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s001">Text S1</xref></bold>
###xml 164 167 164 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 268 271 268 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 347 355 347 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 416 419 416 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 614 617 614 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 777 786 777 786 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 777 786 777 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008764-g002"><bold>Figure 2A</bold></xref>
###xml 1077 1086 1077 1086 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B</bold>
###xml 1077 1086 1077 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008764-g002"><bold>Figure 2B</bold></xref>
###xml 1508 1511 1508 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 1712 1715 1712 1715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 495 500 <span type="species:ncbi:9606">human</span>
###xml 1557 1562 <span type="species:ncbi:9606">human</span>
The analysis described in our Text S1 online indicates that our results could all be accounted for by a simple model where v311 is the only variant that influences IDE function. For this reason and because v311 showed the strongest association with increased level of IDE transcript, we evaluated its functional effect on reporter gene expression in vitro (unlike rs7910977, v311 is located in a conserved region of IDE and is therefore more likely to be a functional variant). Two immortalized human cell lines (Be(2)-C neuroblastoma and HepG2 hepatocytoma) were transfected with expression constructs containing IDE sequence surrounding v311. Major (G) and minor (A) allele sequences were cloned either 5' to the promoter or 3' to the gene. In neuroblastoma (Be(2)-C) cells (Figure 2A), transfection of the 5'A (minor allele) construct significantly increased reporter gene expression compared to the 5'G (major allele) construct (5'A vs 5'G = 1.35-fold increase in reporter expression, p = 0.006, n = 5). This result replicated well in HepG2 hepatocellular carcinoma cells (Figure 2B: 5'A vs 5'G = 1.31-fold increase in reporter expression, p = 0.02, n = 3). In Be(2)-C cells the same allele-specific reporter expression was observed for the 3' constructs (3'A vs 3'G fold-increase = 1.35, p = 0.05), but this was not apparent in HepG2 cells (3'A vs 3'G fold-change = 0.98, p = 0.44). This analysis of reporter gene expression focuses on the effect of the v311 locus in two cell lines where regulation of IDE expression is likely to be different than in human cerebellum. The results of this analysis do, nonetheless, provide useful supporting evidence that v311 is a functional variant that acts to increase IDE gene expression thereby decreasing Ass and decreasing risk for LOAD.
###end p 26
###begin title 27
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro functional effects of variant 311 (rs6583817) on reporter gene expression.
###end title 27
###begin p 28
###xml 65 66 65 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 81 82 81 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1034 1037 1034 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 403 407 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
pGL3P constructs containing v311 sequence were transfected into (A) Be(2)-C and (B) HepG2 cell lines. 5' and 3' refer to the position of the cloned sequences relative to the luciferase gene and promoter in the pGL3P vector. G refers to vectors containing v311 major allele sequence and A refers to vectors containing v311 minor allele sequence. P refers to the pGL3P positive control vector (containing SV40 promoter) and B refers to the pGL3B negative control vector (containing no promoter). Error bars represent SEM (standard error of the mean). Note that the major allele sequence encompassing v311 had a repressor effect in Be(2)-C cells that achieved significance when the 3'G construct was compared to the pGL3P positive control vector (P) alone (fold-change = 0.48, p = 0.04). In contrast, the wild type sequence had a significant enhancer effect when the 3'G construct was compared to pGL3P in HepG2 cells (5'G fold-change = 2.4, p = 0.02, 3'G fold-change = 1.5). This difference probably reflects differential regulation of IDE expression by the transcription factors expressed in each cell line.
###end p 28
###begin p 29
###xml 264 267 264 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 289 296 289 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 289 296 289 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008764-t001"><bold>Table 1</bold></xref>
###xml 372 379 372 379 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 372 379 372 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008764-t002"><bold>Table 2</bold></xref>
###xml 682 685 682 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Variant 3 (v3) is in near perfect linkage disequilibrium with v311 but it occurs less frequently that v311. Thus v3 tags only one of the two haplotypes that include v311 (H9 but not H6), and both haplotypes show essentially identical association with the level of IDE transcript in brain (Table 1). Our point estimates of ORs for the association of v3 and v311 with LOAD (Table 2) suggest that v3 may have a stronger protective effect than v311, but the 95% CIs for the ORs of these two variants are completely overlapping. Thus we have insufficient power to determine whether the protective effects of the two variants are truly different, and the association of v3 with increased IDE transcript and reduced risk of LOAD could be due entirely to a functional effect of v311.
###end p 29
###begin p 30
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 301 304 301 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 348 357 348 357 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 348 357 348 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008764-g003"><bold>Figure 3A</bold></xref>
###xml 658 667 658 667 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3B</bold>
###xml 658 667 658 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008764-g003"><bold>Figure 3B</bold></xref>
###xml 173 178 <span type="species:ncbi:9606">human</span>
To determine if v3 might also contribute functionally to increased IDE expression, we evaluated its functional effect on reporter gene expression in vitro. Two immortalized human cell lines (Be(2)-C neuroblastoma and HepG2 hepatocytoma) were transfected with expression constructs containing 248bp of IDE sequence surrounding v3. In Be(2)-C cells (Figure 3A), transfection of the minor allele (C) construct significantly decreased reporter gene expression compared to the major allele (-) construct in both 5' and 3' locations (5'C vs 5'-; fold-change = 0.77, p = 0.03, 3'C vs 3'-; fold-change = 0.29, p = 0.0001). This result was replicated in HepG2 cells (Figure 3B: 5'C vs 5'-; fold-change = 0.67, p = 0.02, 3'C vs 3'-; fold-change = 0.26, p = 0.0008).
###end p 30
###begin title 31
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro functional effects of variant 3 (rs5786996) on reporter gene expression.
###end title 31
###begin p 32
###xml 186 187 186 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 202 203 202 203 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 503 507 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Note that variant 3 (-/C) has a single C insertion. Thus the major allele is indicated by a - and the minor allele by a C. pGL3P constructs containing v3 sequence were transfected into (A) Be(2)-C and (B) HepG2 cell lines. 5' and 3' refer to the position of the cloned sequences relative to the luciferase gene and promoter in the pGL3P vector. "-" = vector containing v3 major allele sequence, "C" = vector containing v3 minor allele insertion sequence, "P" = pGL3P positive control vector (containing SV40 promoter), "B" = pGL3B negative control vector (containing no promoter). Error bars represent standard error of the mean. Note that in Be(2)-C cells, the v3 sequence had a repressor effect when compared to the pGL3P positive control vector (P) alone that achieved significance (5'C; fold-change = 0.82, p = 0.03, 3'-; fold-change = 0.65, p = 0.001; 3'C; fold-change = 0.19, p<0.0001) for all except the 5'- major allele sequence that showed no significant change in expression. In HepG2 cells, the 5'major allele sequence had an enhancer effect (5'-; fold-change = 1.62, p = 0.008) while the 5'C vector showed no significant change in expression compared to P. Both 3' constructs had repressor activity (3'- fold-change = 0.56, p = 0.0008, 3'C fold-change = 0.14, p<0.0001).
###end p 32
###begin p 33
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 400 405 <span type="species:ncbi:9606">human</span>
These results showing that v3 is associated with decreased expression in vitro make it unlikely that v3 functions to increase IDE expression in brain and suggest that the association of v3 with increased transcript in brain and reduced risk of LOAD may be due to its strong linkage disequilibrium with v311. These results underscore the limitation of pursuing SNP/transcript associations observed in human brain by analyzing reporter gene expression in cell lines where regulation may differ considerably from that in brain. The mechanism of the increased expression we observed in vitro and the implications, if any, for mechanisms operative in brain are uncertain.
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 133 136 133 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 703 706 703 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 752 755 752 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
We incorporated several elements into the design of this study that were intended to improve our ability to determine whether or not IDE has LOAD susceptibility alleles. First, we focused on variants in conserved regions. Like other markers, these variants can detect un-typed functional variants indirectly through linkage disequilibrium. They are advantageous because they are more likely to play a functional role in disease development than anonymous polymorphisms and are therefore expected to have higher power to detect genetic associations. Second, in an effort to detect the net effect of associations from multiple variants, we tested for global haplotypic association. Third, we tested these IDE haplotypes and variants for association with IDE gene expression levels. Fourth, we evaluated a large series of 3,529 cases and 3,441 controls to increase our power to detect weak associations with LOAD. Finally, we used results from a separate genome wide scan to test for association with the level of Ass40, Ass42 and the sum of the two, in plasma.
###end p 35
###begin p 36
###xml 261 264 261 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Because it is a single test, it is reasonable to minimize multiple testing of the 17 variants identified in conserved regions by beginning with global tests of haplotypic association. This approach was effective. Global haplotypic association with the level of IDE transcript was highly significant (p = 0.003), and global haplotypic association with LOAD was also significant (p = 0.02).
###end p 36
###begin p 37
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 166 168 166 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 315 318 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Testing for association with the level of IDE transcript was also useful at the single variant level. The variants showing strongest association were v311 (p = 1.5x10-8) and v3 (p = 0.0005). These significant, functionally meaningful associations provide a powerful rationale for prioritizing the testing of the 17 IDE variants for association with LOAD beginning with these two expression SNPs (eSNPs). When assessed in the LOAD case-control series, these variants did in fact show significant (p<0.03) association with reduced risk of LOAD.
###end p 37
###begin p 38
###xml 285 288 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 372 375 372 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 729 732 729 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 1009 1012 1009 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 1307 1310 1307 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
It is likely that some LOAD susceptibility alleles alter gene function similarly in affected and unaffected brain regions and even in peripheral tissues and lymphoblastoid cell lines, whereas others alter gene function selectively in affected brain regions. In this study, we analyzed IDE mRNA in LOAD brain tissue obtained at autopsy to improve detection of LOAD-related IDE variant/transcript associations that might go undetected in peripheral tissues or lymphoblastoid cell lines. Because LOAD causes profound neuronal cell loss and astrogliosis that will alter mRNA levels in affected regions, mRNAs were measured in the cerebellum which is largely unaffected by LOAD pathology. This approach presupposes that at least some IDE variant/transcript associations relevant to LOAD can be detected not only in affected brain regions but also in cerebellum. mRNAs are degraded in the postmortem interval, and mRNA levels are likely to be influenced by the agonal state prior to death. These factors will alter IDE transcript level, but they can have a similar effect in carriers and non-carriers of functionally important variants that does not alter the difference in transcript level between carriers and non-carriers. This probably explains why we were able to detect unequivocal, functionally meaningful IDE variant/transcript associations using samples obtained at autopsy from only 194 subjects.
###end p 38
###begin p 39
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Collectively our findings provide the best evidence to date that IDE has susceptibility alleles for LOAD. More generally, they suggest that targeted testing of expression SNPs (eSNPs) strongly associated with altered transcript levels in brain samples frozen at autopsy may be a powerful way to identify genetic associations with CNS diseases that would otherwise be difficult to detect.
###end p 39
###begin title 40
Materials and Methods
###end title 40
###begin title 41
Ethics Statement
###end title 41
###begin p 42
###xml 159 163 <span type="species:ncbi:162683">Mayo</span>
###xml 213 217 <span type="species:ncbi:162683">Mayo</span>
###xml 270 275 <span type="species:ncbi:9606">Human</span>
Approval was obtained from the ethics committee or institutional review board of each institution responsible for the ascertainment and collection of samples (Mayo Clinic College of Medicine, Jacksonville, FL and Mayo Clinic College of Medicine, Rochester, MN, USA; MRC Human Genetics Unit, Western General Hospital and the University of Edinburgh Medical School, Edinburgh, UK; University of Split Medical School and University Hospital "Sestre Milosrdnice", Croatia; Queen's Medical Centre, Nottingham, UK; Queen's University Belfast, Northern Ireland, UK; University of Bristol, Frenchay Hospital, UK; University of Manchester, UK; University of Oxford, UK; and University of Bonn, Germany. Written informed consent was obtained for all individuals that participated in this study.
###end p 42
###begin title 43
Case-Control Subjects
###end title 43
###begin p 44
###xml 137 145 137 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s003">Table S1</xref>
###xml 137 145 137 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s003">Table S1</xref></bold>
The age-at-diagnosis/entry, diagnosis method, and percent female in the LOAD cases and controls for each USA and ART series are shown in Table S1.
###end p 44
###begin title 45
USA Case-Control Subjects
###end title 45
###begin p 46
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-McKhann1">[45]</xref>
###xml 134 138 <span type="species:ncbi:162683">Mayo</span>
###xml 299 303 <span type="species:ncbi:162683">Mayo</span>
###xml 373 377 <span type="species:ncbi:162683">Mayo</span>
###xml 458 462 <span type="species:ncbi:162683">Mayo</span>
###xml 844 848 <span type="species:ncbi:162683">Mayo</span>
The USA case-control series consisted of 5,173 Caucasian subjects from the United States (2,513 AD, 2,660 control) ascertained at the Mayo Clinic (1,811 AD, 2,451 controls) or through the National Cell Repository for Alzheimer's Disease (NCRAD: 702 AD, 209 control). All subjects ascertained at the Mayo Clinic in Jacksonville, Florida (JS: 632 AD, 660 control) and at the Mayo Clinic in Rochester, Minnesota, (RS: 576 AD, 1,417 control) were diagnosed by a Mayo Clinic neurologist. The neurologist confirmed a Clinical Dementia Rating score of 0 for all JS and RS subjects enrolled as controls; cases had diagnoses of possible or probable AD made according to NINCDS-ADRDA criteria [45]. In the autopsy-confirmed series (AUT: 603 AD, 374 control), all brains were evaluated by Dr. Dennis Dickson and came from the brain bank maintained at the Mayo Clinic in Jacksonville, FL. In the AUT series the diagnosis of definite AD was also made according to NINCDS-ADRDA criteria. All AD brains analyzed in the study had a Braak score of 4.0 or greater. Brains employed as controls had a Braak score of 2.5 or lower but often had brain pathology unrelated to AD and pathological diagnoses that included vascular dementia, frontotemporal dementia, dementia with Lewy bodies, multi-system atrophy, amyotrophic lateral sclerosis, and progressive supranuclear palsy. One AD case from each of the 702 late-onset NCRAD families was analyzed. NCRAD AD cases were selected based on strength of diagnosis (autopsy-confirmed: 32%>probable: 45%>possible: 8%>family report: 15%); the case with the earliest age at diagnosis was taken when several cases had equally strong diagnoses. The 209 NCRAD controls that we employed were unrelated Caucasian subjects from the United States with a Clinical Dementia Rating of 0, specifically collected for inclusion in case-control series.
###end p 46
###begin title 47
Alzheimer's Research Trust (ART) Case-Control Subjects
###end title 47
###begin p 48
###xml 129 137 129 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s003">Table S1</xref>
###xml 129 137 129 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s003">Table S1</xref></bold>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-McKhann1">[45]</xref>
###xml 238 246 <span type="species:ncbi:9606">patients</span>
Samples from a total of 1,797 subjects were obtained from five Alzheimer's Research Trust, UK (ART) network centers, as shown in Table S1. All samples were from subjects who were diagnosed clinically using NINCDS-ADRDA criteria [45]. All patients with evidence of an autosomal dominant AD trait, or where a first degree relative had been diagnosed with familial AD, were excluded. Since there were no controls available for the Manchester series, the Manchester AD samples were combined with those in the Oxford series when the individual series were analyzed.
###end p 48
###begin title 49
DNA Isolation
###end title 49
###begin p 50
For the JS and RS samples, DNA was isolated from whole blood using an AutoGen instrument (AutoGen, Inc, Holliston, MA). The DNA from AUT samples was extracted from cerebellum using Wizard(R) Genomic DNA Purification Kits (Promega Corp., Madison, WI). DNA from the RS and AUT series was scarce, so samples from these two series were subjected to whole genome amplification using the Illustra GenomiPhi V2 DNA Amplification Kit (GE Healthcare Bio-Sciences Corp., Piscataway, NJ).
###end p 50
###begin p 51
For the ART samples, genomic DNA was extracted from whole blood samples or brain tissue using the QIAamp DNA blood mini kit (Qiagen, Crawley, West Sussex, UK).
###end p 51
###begin title 52
Variant Discovery
###end title 52
###begin p 53
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 450 455 <span type="species:ncbi:9606">human</span>
###xml 460 465 <span type="species:ncbi:10090">mouse</span>
###xml 490 495 <span type="species:ncbi:9606">human</span>
###xml 500 503 <span type="species:ncbi:10116">rat</span>
###xml 595 600 <span type="species:ncbi:9606">human</span>
###xml 665 670 <span type="species:ncbi:9606">Human</span>
###xml 766 771 <span type="species:ncbi:10090">Mouse</span>
###xml 786 789 <span type="species:ncbi:10116">Rat</span>
Conserved segments in the region encompassing all 25 exons of IDE and up to 10 kb from the 5' and 3' ends of the gene, were screened for DNA variation likely to be functional in a subset of the JS series (269 cases and 252 controls). This sample size gave us enough power to detect all polymorphisms that occur at a frequency >1% in this population. The criteria used for conservation was a cut-off of >/=70% identity over 100 bp windows between the human and mouse sequence or between the human and rat sequence, as determined by the pre-computed alignments in the VISTA Genome Browser (). The human genome position screened was chr10:94,335,255-94,475,049 in the Human April 2003 genome build. The latter build was used as the base genome, and was compared to the Mouse Feb. 2003 and Rat Jan. 2003 builds.
###end p 53
###begin p 54
###xml 658 659 646 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 2104 2112 2049 2057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s004">Table S2</xref>
###xml 2104 2112 2049 2057 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s004">Table S2</xref></bold>
###xml 1970 1974 <span type="species:ncbi:162683">Mayo</span>
In each of the 521 subjects screened, we evaluated 40 amplicons that contained a total of 9,501 bp of conserved DNA. This DNA included all exons (5,954 bp) as well as conserved regions located up to 10kb from the gene's 5' end (268 bp), up to 10kb from the gene's 3' end (1,465 bp), and 1,814 bp of highly conserved intronic sequence. Forty PCR primer pairs were designed to screen the targeted conserved segments via denaturing high performance liquid chromatography (dHPLC). PCR amplicons were generated with 20ng of DNA in a 50ul PCR containing 0.2microM forward primer, 0.2microM reverse primer, 200microM dNTPs, 5ul of 10x reaction buffer with 25mM MgSO4 (Transgenomic, Inc.), and 1 Unit of Optimase(R) Polymerase (Transgenomic, Inc.), using one of the following three conditions in a Hybaid thermocycler: 60-50 Touchdown, 62-57 Touchdown, or 55-45 Touchdown. Each PCR product was denatured at 95degreesC for 10 min and cooled slowly to 25degreesC at a rate of 0.03degreesC/sec to encourage heteroduplex formation. 5microl of each sample was injected into a DNASep(R) HT Cartridge 6.5mmx37mm (Transgenomic, Inc.) and analyzed in a WAVE DHPLC instrument (Transgenomic, Inc.) to identify heterozygotes. The optimal oven temperature and WAVE Optimized(R) buffer gradient for DHPLC analysis of each amplicon was selected using the Navigatortrade mark software (Transgenomic, Inc.). Samples were categorized as either heteroduplexes or homoduplexes, based on the resulting elution profiles as recommended by Transgenomic, Inc. Representative homoduplexes and heteroduplexes from each amplicon were sequenced in order to determine the nature of the DNA variation underlying each heteroduplex profile. 20microl of remaining PCR product from the selected samples were purified for the sequencing reaction using the MultiScreen(R) PCR96 Filter Plates (Millipore). Sequencing in the forward and reverse orientation was performed at the Molecular Biology Core Facility at the Mayo Clinic, Rochester, MN as described on their website (). This variant discovery effort yielded 53 variants (42 novel, as shown in Table S2) of which 14 had minor allele frequencies (MAFs) >1%. Twelve of these were genotyped, 2 could not be converted into TaqMan assays (deep intronic, 1 base insertions within simple repeats).
###end p 54
###begin p 55
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 706 709 706 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 939 953 939 953 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Genotyping of </bold>
###xml 953 956 953 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 953 956 953 956 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>IDE</italic></bold>
###xml 956 965 956 965 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> variants</bold>
###xml 1211 1215 1209 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Barrett1">[46]</xref>
###xml 388 393 <span type="species:ncbi:9606">human</span>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
###xml 623 628 <span type="species:ncbi:10090">mouse</span>
###xml 633 638 <span type="species:ncbi:9606">human</span>
###xml 771 776 <span type="species:ncbi:9606">human</span>
###xml 781 786 <span type="species:ncbi:10090">mouse</span>
###xml 984 988 <span type="species:ncbi:162683">Mayo</span>
To complement our de novo search for conserved variants, we developed a web based application called SNPMiner to mine known variants in conserved regions. As input the application takes a standard NCBI query string and/or a set of chromosomal coordinates. In real time, the application collects information from dbSNP () on all variants that satisfy the input. Using VISTA's pre-computed human vs. mouse sequence alignments, which have been downloaded into our local server, SNPMiner scans all 100 bp regions encompassing each variant retrieved from dbSNP and identifies the 100 bp region with maximum identity between the mouse and human sequence. In this fashion, we identified all known variants in the IDE gene or its 10 kb flanks that were in conserved regions with human vs. mouse sequence identity >70%. The variants in conserved regions that had MAF information in dbSNP were genotyped, as described below in the section entitled "Genotyping of IDE variants", in at least the Mayo JS series to determine if they met the MAF cut-off of >/=0.01. In the case of variants that did not have MAF information in dbSNP, dHPLC was used as described above to estimate their frequency. In the JS series, HaploView [46] was employed to determine the degree of linkage disequilibrium between the variants identified through our de novo search that could be genotyped with TaqMan assays.
###end p 55
###begin p 56
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 331 339 327 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s004">Table S2</xref>
###xml 331 339 327 335 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s004">Table S2</xref></bold>
###xml 359 362 355 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 433 436 429 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 506 516 502 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s002">Figure S1a</xref>
###xml 506 516 502 512 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s002">Figure S1a</xref></bold>
###xml 591 601 587 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s002">Figure S1b</xref>
###xml 591 601 587 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s002">Figure S1b</xref></bold>
###xml 652 660 648 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s004">Table S2</xref>
###xml 652 660 648 656 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s004">Table S2</xref></bold>
###xml 153 158 <span type="species:ncbi:10090">mouse</span>
###xml 163 168 <span type="species:ncbi:9606">human</span>
Our review of all known IDE variants identified 15 additional variants, each located in a 100 bp region that had sequence identity of >/=70% between the mouse and human sequence. Of these, 8 had MAFs>/=1%. Three of these were in perfect LD with variants from the de novo search, thus were eliminated (Variant IDs 925, 931 and 934, Table S2) leaving 17 common IDE variants in conserved regions to be genotyped. The location of the 68 IDE variants in conserved regions is shown relative to gene structure in Figure S1a. The locations of the 17 common variants that were genotyped are shown in Figure S1b. All 68 conserved variants are fully described in Table S2, where the 17 variants that were genotyped are shown in boldface type.
###end p 56
###begin title 57
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Genotyping of IDE Variants
###end title 57
###begin p 58
###xml 315 319 <span type="species:ncbi:162683">Mayo</span>
Variants found in conserved regions via dHPLC and those found in dbSNP having known MAFs were selected for genotyping. Conserved variants in dbSNP without known MAF were genotyped only if they were observed at least once via dHPLC analysis of 182 subjects. All genotyping of USA series samples was performed at the Mayo Clinic in Jacksonville using TaqMan(R) SNP Genotyping Assays in an ABI PRISM(R) 7900HT Sequence Detection System with 384-Well Block Module from Applied Biosystems, California, USA. The genotype data was analyzed using the SDS software version 2.2.2 (Applied Biosystems, California, USA).
###end p 58
###begin p 59
The ART data, was also generated with TaqMan assays performed at Geneservice (Cambridge, UK). Fifteen percent of the samples assayed were of known genotype, determined by sequencing, which were unknown to Geneservice, but known at source and 10% were genotyped in duplicate as a quality assurance measure. The data were only accepted when there was 100% concordance between duplicate samples.
###end p 59
###begin p 60
###xml 149 157 149 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s005">Table S3</xref>
###xml 149 157 149 157 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s005">Table S3</xref></bold>
Details of the variants investigated in this study, including location, MAF, Hardy-Weinberg equilibrium p values and genotype counts can be found in Table S3.
###end p 60
###begin title 61
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
IDE Haplotypes
###end title 61
###begin p 62
###xml 22 26 22 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Barrett1">[46]</xref>
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 118 128 118 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s002">Figure S1c</xref>
###xml 118 128 118 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s002">Figure S1c</xref></bold>
###xml 168 176 168 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s006">Table S4</xref>
###xml 168 176 168 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s006">Table S4</xref></bold>
###xml 352 355 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 543 547 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Schaid1">[47]</xref>
Analysis by HaploView [46] (solid spine of LD) showed that the 17 IDE variants were in strong linkage disequilibrium (Figure S1c). These variants formed 11 haplotypes (Table S4) with a frequency of 1.0% or more that could be identified with 10 tagging variants. Analysis by Haplo.Stats identified the same 11 haplotypes, which accounted for 96% of the IDE genetic variation captured by the 17 variants. Haplotype frequencies were estimated using the expectation-maximization approach implemented in the haplo.em function of haplo.stats v1.2.2 [47]. Haplo.stats was also used to create files showing the inferred haplotypes for each individual, which were used to perform logistic regression analyses.
###end p 62
###begin title 63
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Measurement of IDE mRNA Expression
###end title 63
###begin p 64
###xml 603 606 603 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 645 646 645 646 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
Total RNA was extracted from samples of cerebellum from 200 AD brains using an ABI PRISM 6100 Nucleic Acid PrepStation and the Total RNA Isolation Chemistry kit from Applied Biosystems. RNA was reverse transcribed to single-stranded cDNA using the High-Capacity cDNA Archive Kit from Applied Biosystems. Real-time quantitative PCR was performed in triplicate for each sample using ABI TaqMan Low Density expression Arrays (384-Well Micro Fluidic Cards) with a pre-validated TaqMan Gene Expression Assay. 18s ribosomal RNA (18s rRNA) was used as the endogenous control for the relative quantification of IDE mRNA. Real-time PCR cycle threshold (CT) raw data was collected and exported using the ABI PRISM(R) SDS software version 2.2.
###end p 64
###begin p 65
###xml 14 15 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 163 164 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 210 211 206 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 227 230 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
The variable CT within the raw data file indicates the PCR cycle number at which the amount of amplified gene target reaches a fixed threshold. The variable DeltaCT denotes the difference between the averaged CT values for the IDE transcript and that for the reference 18S rRNA transcript.
###end p 65
###begin p 66
###xml 10 11 6 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 118 121 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 148 151 144 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
The DeltaCT values calculated from each sample were used as quantitative phenotypes to determine associations between IDE variants and the level of IDE transcript. Some samples had one or more replicate measurements that failed to amplify and were obvious outliers, thus they were excluded from the analysis. All samples included for analysis had at least two replicates with a SEM </=0.35.
###end p 66
###begin title 67
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Association of IDE Haplotypes and Variants with the Level of IDE Transcript
###end title 67
###begin p 68
###xml 166 167 161 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 205 206 200 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 239 243 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 342 347 331 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(&#8722;&#223;)</sup>
###xml 441 455 429 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">[&#8722;(&#223;&#177;2SEM)]</sup>
###xml 631 634 616 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 815 816 796 797 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 915 916 892 893 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 1050 1051 1019 1020 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 1088 1089 1049 1050 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 1108 1109 1069 1070 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1250 1263 1211 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;CT</sup>
###xml 1279 1291 1228 1240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T_Any Sample</sub>
###xml 1303 1322 1248 1267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T_Major Homozygotes</sub>
###xml 1334 1347 1279 1284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;CT</sup>
###xml 970 978 <span type="species:ncbi:261946|species:ncbi:501646|species:ncbi:34344|species:ncbi:526811|species:ncbi:338539|species:ncbi:369518">e. major</span>
The fold difference in the expression levels for the minor allele was estimated from the regression coefficient (ss) for the additive model that was fit to the DeltaCT data, which were expressed on the log2 scale, while also adjusting for APOE epsilon4 dosage, age at diagnosis/entry and sex. Therefore, we summarized the associations using 2(-ss) to estimate the fold difference in expression due to a single copy of the minor allele, and 2[-(ss+/-2SEM)] to estimate the corresponding 95% confidence interval (CI). We further summarized the expression differences graphically by preparing box plots showing the relative amount of IDE transcript in any sample in the series as compared to the mean expression level of all of the samples that were major homozygotes. This was done by computing the mean of all DeltaCT values for the samples in the major homozygote category and subtracting it from each of the DeltaCT values for all samples in all genotype categories (i.e. major homozygotes, heterozygotes and minor homozygotes) to obtain DeltaDeltaCT values. Given that these DeltaDeltaCT values are the log2 fold changes between two measurements, the relative expression levels between any sample and the mean of the major homozygotes is given by 2-DeltaDeltaCT  =  2(-(DeltaCT_Any Sample-mean(DeltaCT_Major Homozygotes))). These 2-DeltaDeltaCT values are plotted in the box plots.
###end p 68
###begin p 69
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 130 131 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 253 257 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 381 384 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 403 404 383 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 510 514 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
The overall association between estimated haplotypes (frequency >0.01 in combined dataset) and the level of IDE transcript (DeltaCT) was determined by multivariable linear regression using a haplotypic dosage model with sex, age at diagnosis/entry, and APOE epsilon4 dosage (0, 1 or 2 copies of the epsilon4 alelle) as covariates. The association between individual haplotypes and IDE transcript (DeltaCT) was determined by linear regression using an allelic dosage model with sex, age at diagnosis/entry, and APOE epsilon4 dosage as covariates. The haplo.stats package was used to create the files containing the inferred haplotypes for each individual that were used to perform these analyses.
###end p 69
###begin p 70
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 83 84 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 211 215 207 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
IDE variants were analyzed for association with the level of IDE transcript (DeltaCT) using an additive/allelic dosage (11 = 0, 12 = 1, 22 = 2) linear regression model that included sex, age at diagnosis/entry, APOE epsilon4 dosage and series as covariates.
###end p 70
###begin title 71
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Power to Detect Association between IDE Variants and the Level of IDE Transcript
###end title 71
###begin p 72
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 533 536 533 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 595 596 591 592 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 880 881 872 873 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 997 1008 989 1000 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1.13&#215;effect</sup>
###xml 1099 1108 1091 1100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1.13&#215;1.11</sup>
In our AUT series, we obtained IDE transcript levels from 194 LOAD brains. Using power formulae for an ordinal test of significance across the three possible genotypes using linear regression, we computed the detectable effect size while setting the power at 80% for a 0.05 level test for selected minor allele frequencies. Although the identified variants were in high LD, we re-computed these estimates after correcting for the 17 tests performed. With the sample size available to us, and with the minor allele frequencies of the IDE variants, we had 80% power to detect differences in DeltaCT values at least 1.11, 0.48 and 0.30 standard deviations for variants with MAFs of 1.7%, 10.3% and 35.5%, respectively. After applying Bonferroni corrections for 17 variants, these detectable effect sizes climbed to 1.52, 0.65 and 0.41. Given that the standard deviation of the DeltaCT values is 1.13, these detectable effect sizes correspond to fold-differences between carriers and non-carriers of 21.13xeffect. For the tests performed at the nominal level, for example, we had 80% power to detect a 21.13x1.11 = 2.39-fold per-copy effect for the most rare variant and a 1.29-fold per-copy effect for the most common variant.
###end p 72
###begin title 73
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Association of IDE Haplotypes and Variants with LOAD
###end title 73
###begin p 74
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Schaid1">[47]</xref>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 563 567 557 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
The overall association between haplotypes (frequency >0.01 in combined dataset) and LOAD was determined using the global score statistic implemented in the haplo.score function incorporated in the haplo.stats package [47] while adjusting for sex, age at diagnosis/entry, APOE epsilon4 dosage, and series effects. The association between individual haplotypes and LOAD was determined by entering the estimated haplotypes for the cases and controls into univariate logistic regression using a haplotypic dosage model that adjusted for sex, age at diagnosis/entry, APOE e4 dosage, and series as covariates.
###end p 74
###begin p 75
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Purcell1">[48]</xref>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
IDE variants were analyzed for association with LOAD by logistic regression using PLINK software [48] with sex, age at diagnosis/entry, and APOE epsilon4 dosage as covariates. For logistic regression using data from the combined series, we also included indicator variables for the individual series as covariates. All logistic regression analyses were performed using the additive/allelic dosage model as the primary test of significance for each variant. To test for evidence of any series-related effects on these associations, we compared this model to one that also incorporated series x genotype interactions in addition to all previously mentioned covariates. This analysis showed no evidence for series-related effects on any of the associations.
###end p 75
###begin title 76
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Power to Detect Association between IDE Variants and LOAD
###end title 76
###begin p 77
###xml 233 236 233 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Slager1">[49]</xref>
###xml 813 816 813 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
We have assembled the largest case-control series for LOAD genetic association studies available to date. In our combined series, we obtained samples from 3,529 cases and 3,441 controls. The minor allele frequencies (MAFs) of the 17 IDE variants identified in the conserved regions of the gene ranged from 1.7% to 35.5% with a median of 10.3%. Using power for the Armitage test for trend [49], we computed the minimum odds ratios (ORs) greater than one, and the maximum ORs less than one, that could be detected in a sample of this size while setting the power at 80% for a 0.05 level test. Although the identified variants were in high LD, we re-computed these estimates after a Bonferroni correction for the 17 tests performed. With the sample size available to us, and with the minor allele frequencies of the IDE variants, we had 80% power to detect ORs of at least 1.40, 1.17 and 1.11, or no more than 0.66, 0.85 and 0.90, for variants with MAFs of 1.7%, 10.3% and 35.5%, respectively. After applying Bonferroni corrections for 17 variants, the ORs greater than one climbed to 1.54, 1.22 and 1.14 and the ORs less than one dropped to 0.57, 0.80 and 0.87.
###end p 77
###begin title 78
Linkage Disequilibrium between rs6583817 (v311) and rs7910977
###end title 78
###begin p 79
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Carrasquillo1">[10]</xref>
###xml 318 321 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 448 449 448 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 523 526 523 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 578 581 578 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 808 811 808 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 868 870 868 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
We previously conducted a LOAD genome wide association study (GWAS) with 313,504 SNPs in 844 cases and 1,255 controls that were also analyzed for association with the 17 IDE variants in conserved regions [10]. HaploView 3.1 was used to calculate the extent of LD between these 17 variants and the GWAS SNPs located in IDE or its 100 kb flanking regions. This analysis showed that GWAS SNP rs7910977 was in strong linkage disequilibrium with v311 (r2 = 0.996 and D' = 1) identified in the current study. The measurements of IDE transcript levels described in the "Measurement of IDE mRNA expression" section above included 174 cerebellar samples obtained at autopsy from subjects that were part of our LOAD GWAS. Consistent with the results we report for v311, rs7910977 associated strongly with the level of IDE transcript in these 174 samples with a p value of 2.7x10-8 that was significant at the genome-wide level. rs7910977 also showed significant association with LOAD in the 2,099 subjects analyzed in the GWAS (p = 0.005).
###end p 79
###begin title 80
Association of rs7910977 with Plasma Abeta40 and Abeta42
###end title 80
###begin p 81
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Vitart1">[42]</xref>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Zemunik1">[44]</xref>
###xml 468 472 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Vitart1">[42]</xref>
###xml 474 478 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Zemunik1">[44]</xref>
###xml 631 635 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Suzuki1">[50]</xref>
###xml 637 641 629 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Scheuner1">[51]</xref>
###xml 1229 1235 <span type="species:ncbi:9606">person</span>
rs7910977 was genotyped as part of two genome-wide association studies of the Dalmatian island populates of Vis and Korcula, using Illumina genotyping platforms [42], [44]. Genotypes for this SNP were present (following quality control) for 883 of the 949 subjects with plasma Abeta measurements in the Vis study and 876 of the 930 subjects with plasma Abeta measurements in the Korcula study. Study samples from Vis and Korcula were collected as described previously [42], [44] and plasma levels of the Ass40 and Ass42 peptides were measured, in duplicate, using a well established sandwich ELISA system, also described elsewhere [50], [51]. Antibody pairs BNT77/BC05 were used to measure plasma Abeta42 in both populations, the BAN50/BA27 pair was used to measure Abeta40 in the Vis population and the BNT77/BA27 pair was used to measure Abeta40 in the Korcula population. The ELISA assays were repeated for individuals that had a coefficient of variation (CV) of greater than 0.2 for the duplicate measurements; following repetition of these measurements the median value was used as the estimate of the plasma Abeta value. A third trait was created termed "total Ass" by summing these raw values for Ass40 and Ass42 for each person. This trait was then analysed in the same manner as the Ass40 and Ass42 traits individually.
###end p 81
###begin p 82
###xml 22 26 22 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008764-Aulchenko1">[52]</xref>
###xml 804 812 800 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008764.s007">Table S5</xref>
###xml 804 812 800 808 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0008764.s007">Table S5</xref></bold>
###xml 185 197 <span type="species:ncbi:9606">participants</span>
The R package GenABEL [52] was used for association analysis where a kinship matrix was generated using genotypic data from the genome wide scan to control for relatedness of the study participants. The distribution of data values for Ass40, Ass42 and totalAss did not meet the assumption of normality and so a rank transformation was implemented in GenABEL to normalize the data distributions. Using the polygenic and mmscore functions available in GenABEL we tested the additive effect of the minor allele (T) for this SNP on the transformed plasma Ass phenotypes including covariates for age and sex in the model. Using the functions available in the related R package MetABEL () we performed meta analysis for this SNP using the Vis and Korcula populations. The results of this analysis are shown in Table S5.
###end p 82
###begin title 83
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
Preparation of IDE v311 Construct
###end title 83
###begin p 84
###xml 233 289 233 289 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GGGGACAAGTTTGTACAAAAAAGCAGGCT-TGGTCATTTTGGAGATGTGG 3&#8242;</named-content>
###xml 299 355 299 355 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GGGGACCACTTTGTACAAGAAAGCTGGGT-TCACACAGCATTGTTTTCCA 3&#8242;</named-content>
###xml 564 565 564 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 88 92 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1105 1109 <span type="species:ncbi:162683">Mayo</span>
###xml 1400 1406 <span type="species:ncbi:110766|species:ncbi:562">E.coli</span>
###xml 2345 2349 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
A 149bp fragment containing v311 was cloned into a luciferase pGL3 vector containing an SV40 promoter (Promega) using the Gateway cloning system (Invitrogen). AttB-flanked primers specific to a 149bp region surrounding v311 (forward 5' GGGGACAAGTTTGTACAAAAAAGCAGGCT-TGGTCATTTTGGAGATGTGG 3', reverse 5' GGGGACCACTTTGTACAAGAAAGCTGGGT-TCACACAGCATTGTTTTCCA 3') were used to amplify genomic DNA extracted from individuals known to be homozygous for v311 major or minor allele. PCR reactions were performed in a reaction mix containing 1xPCR buffer containing 1.5mM MgCl2 (QIAGEN), 1mM dNTPs (Promega), 0.2microM each primer, 2.5U HotStar Taq DNA polymerase and 20ng genomic DNA to a final volume of 25microl. Amplification conditions were as follows; 95degreesC for 5 minutes, followed by 35 cycles of 95degreesC for 30 seconds, 54degreesC for 1 minute, 72degreesC for 1 minute and finally an extension step of 72degreesC for 10 minutes. The resultant amplicons (major and minor allele) were extracted from an ethidium bromide-stained agarose gel using a QIAquick Spin kit (QIAGEN) and verified by sequencing (Mayo Clinic, Rochester). The attB-flanked fragments were integrated via bacterial recombination into a kanamycin-resistant pDONR 221 vector using the BP Clonase II system (Invitrogen) to produce an entry clone. Entry clones were transformed into Library efficiency DH5alpha chemically competent E.coli (Invitrogen) and grown on LB agar containing 50microg/ml kanamycin overnight at 37degreesC. Single colonies were picked for inoculation in liquid LB broth containing 50microg/ml kanamycin and incubated overnight in a shaking incubator at 37degreesC. Plasmids were extracted from the bacterial cells using a QIAprep spin kit (QIAGEN). Final expression clones were constructed by recombination of the entry clones with ampicillin-resistant pGL3 promoter vector using the LR Clonase II system (Invitrogen). Expression clones were transformed into DH5alpha E.Coli and grown on LB agar containing 100microg/ml ampicillin and single colonies were inoculated in LB broth containing 100microg/ml ampicillin. Plasmids were extracted using endotoxin-free Zyppy Plasmid miniprep kit (Zymo research) and verified by sequencing. Four expression clones were made in total; 5'G and 5'A contained 311 major (G) or minor (A) sequence positioned 5' to the SV40 promoter and luciferase reporter gene, 3'G and 3'A contained sequence positioned 3' to the luciferase gene.
###end p 84
###begin title 85
Cell Culture
###end title 85
###begin p 86
###xml 389 390 379 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 199 205 <span type="species:ncbi:9913">bovine</span>
Human HepG2 hepatocellular carcinoma and Be(2)-C neuroblastoma immortalized cell lines were supplied by ATCC. Cells were cultured in Eagle Minimum Essential Medium (EMEM) supplemented with 10% fetal bovine serum, 2mM L-Glutamine, 1x non-essential amino acids, 1000U/ml Penicillin-Streptomycin (Sigma), 2.5microg/ml Fungizone (Invitrogen). All cultures were incubated at 37degreesC in 5% CO2.
###end p 86
###begin title 87
Transfections
###end title 87
###begin p 88
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 359 363 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
1x105 Be(2)-C cells or 3x105 HepG2 cells were plated in12-well culture plates 24 hours before transfection. Cells were co-transfected in triplicate with the v311 luciferase expression clones and a pRL vector (Promega) containing Renilla Luciferase reporter gene. Control wells included co-transfection of either pGL3 B (empty pGL3vector) or P (containing the SV40 promoter) with pRL. On day of transfection, cells were washed x2 with PBS and media was replaced with 400microl serum-free EMEM containing 200ng expression clone or control vector, 10ng pRL and transfection reagent Tfx-20 (Promega) at a charge ratio of 3:1 (Tfx:DNA) per well. Transfection mix was pre-incubated for 15 minutes at room temperature. One hour after transfection, 800microl complete EMEM was added to each well.
###end p 88
###begin title 89
Dual Luciferase Assay
###end title 89
###begin p 90
48 hours after transfection, cells were washed x2 with PBS and harvested with 200microl of 1x Lysis buffer (Promega) for 20 minutes on a rocking platform. 5microl lysate was plated in a white 96-well assay plate. Firefly and Renilla luciferase signal were measured on a Veritas microplate luminometer (Turner Biosystems) using the Dual luciferase reporter assay system (Promega). The ratio of Firefly to Renilla luciferase signal was used to normalize firefly activity for intra-experimental transfection efficiency. Unpaired t-tests comparing mean relative firefly signal for our expression clones were performed using Stats Direct.
###end p 90
###begin title 91
Web Resources
###end title 91
###begin p 92
dbSNP:
###end p 92
###begin p 93
Alzgene:
###end p 93
###begin title 94
Supporting Information
###end title 94
###begin p 95
Discussion of single variant and haplotypic associations. Supplementary note.
###end p 95
###begin p 96
(0.04 MB DOC)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin p 98
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 73 76 73 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 224 227 224 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 373 376 373 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 186 191 <span type="species:ncbi:9606">human</span>
###xml 196 201 <span type="species:ncbi:10090">mouse</span>
Location and LD of common conserved IDE variants. (a) Location of the 68 IDE variants that meet conservation criteria (red vertical lines, conservation >70% identity over 100 bp bewteen human and mouse) is shown relative to IDE exons (blue boxes) and UTRs (green boxes). The gene structure is shown in the 5' to 3' orientation from p- to q-telomere. (b) Location of the 17 IDE variants that meet conservation and MAF criteria (MAF>1%). (c) HaploView LD D' plot (solid spine block definition) and the 11 common haplotypes (frequency>1%) formed by these 17 variants.
###end p 98
###begin p 99
(0.20 MB DOC)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin p 101
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Details of samples used in this study. The number of AD patients (AD) and controls (CTRL), mean age, percentage that are female are given for each individual and pooled series. Mean age is given as age at diagnosis/entry. The standard deviation (SD) from the mean is given in parenthesis.
###end p 101
###begin p 102
(0.07 MB DOC)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin p 104
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 305 310 <span type="species:ncbi:9606">Human</span>
Description of IDE conserved variants. Details for the 68 variants identified in our conserved variant screen are provided. The 17 common, conserved variants tested are in bold. Variant ID = "In house" unique variant identifier. rs = dbSNP variant identifier. Position = Chromosomal position based on the Human Genome build 36.1. Location = Variant location relative to the gene structure. a. a. Change = type of amino acid change predicted for variants within exons. Cons max = maximum conservation of any 100 bp window containing the variant. Study MAF = minor allele frequency in the combined USA+ART case control series. dbSNP MAF = minor allele frequency reported by dbSNP as of 10-17-08 (from HapMap-CEU, except for rs1042444 which only had CEPH MAF). dbSNP MAF: VNA = variant not present in dbSNP. dbSNP MAF: NA = MAF not reported in dbSNP. Source: a = found via dHPLC screen; b = found via SNPMiner; c = found via SNPMiner, but confirmed via dHPLC; d = found via dHPLC while confirming a different, neighboring variant found via SNPMiner.
###end p 104
###begin p 105
(0.04 MB XLS)
###end p 105
###begin p 106
Click here for additional data file.
###end p 106
###begin p 107
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
###xml 83 88 <span type="species:ncbi:9606">Human</span>
IDE variant information. The position of each variant is indicated relative to the Human Genome build 36.1. The columns labeled as 1 and 2 indicate the major and minor allele, respectively, and 11, 12, 22 indicate the corresponding genotype counts in all USA and ART combined series for the ten tagging variants (boldface type) and in the USA series for the remaining 7. MAF = minor allele frequency in Controls, Cons = conservation, rs = dbSNP variant identifier, HWp = Hardy-Weinberg p value in controls.
###end p 107
###begin p 108
(0.10 MB DOC)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin p 110
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE</italic>
IDE haplotypes. Haplotypes are numbered according to their frequency in the USA series. Only haplotypes with frequency >0.01 are shown. The "Haplotype" and "Variant ID" columns show the allelic composition of each haplotype in the 5' to 3' orientation from the p to the q telomere of chromosome 10. The allelic composition of each haplotype is depicted as "0" for major allele and "1" for minor allele. The 10 haplotype tagging variants are highlighted in bold.
###end p 110
###begin p 111
(0.08 MB DOC)
###end p 111
###begin p 112
Click here for additional data file.
###end p 112
###begin p 113
Illumina variant (rs7910977), which is in complete LD with v311, showing association with decreased plasma levels of Abeta40 and Abeta42. Association with plasma Abeta was performed using multivariable regression analysis providing coefficient values (negative coefficient represents decrease in plasma Abeta levels).
###end p 113
###begin p 114
(0.05 MB DOC)
###end p 114
###begin p 115
Click here for additional data file.
###end p 115
###begin p 116
###xml 217 225 <span type="species:ncbi:9606">patients</span>
###xml 488 496 <span type="species:ncbi:9606">patients</span>
Samples from the National Cell Repository for Alzheimer's Disease (NCRAD) were used in this study. We thank contributors, including the Alzheimer's Disease Centers who collected samples used in this study, as well as patients and their families, whose help and participation made this work possible. We would also like to thank the Alzheimer's Research Trust for their participation in this collaboration, OPTIMA for providing the Oxford sample collection used in this study, and all the patients, caregivers, and volunteers. We acknowledge especially the help of Elizabeth King and the research nursing team and, for histopathology, Professor M. Esiri and Dr. C. Joachim.
###end p 116
###begin title 117
References
###end title 117
###begin article-title 118
Deciphering the molecular basis of memory failure in Alzheimer's disease.
###end article-title 118
###begin article-title 119
###xml 72 80 <span type="species:ncbi:9606">patients</span>
The current status of Alzheimer's disease genetics: what do we tell the patients?
###end article-title 119
###begin article-title 120
Heritability for Alzheimer's disease: the study of dementia in Swedish twins.
###end article-title 120
###begin article-title 121
The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study.
###end article-title 121
###begin article-title 122
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
###end article-title 122
###begin article-title 123
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.
###end article-title 123
###begin article-title 124
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
###end article-title 124
###begin article-title 125
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.
###end article-title 125
###begin article-title 126
GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.
###end article-title 126
###begin article-title 127
Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.
###end article-title 127
###begin article-title 128
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU</italic>
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PICALM</italic>
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
###end article-title 128
###begin article-title 129
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLU</italic>
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CR1</italic>
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.
###end article-title 129
###begin article-title 130
Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme.
###end article-title 130
###begin article-title 131
Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation.
###end article-title 131
###begin article-title 132
Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
###end article-title 132
###begin article-title 133
Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.
###end article-title 133
###begin article-title 134
###xml 24 29 <span type="species:ncbi:9606">human</span>
Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
###end article-title 134
###begin article-title 135
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta -protein, and the beta -amyloid precursor protein intracellular domain in vivo.
###end article-title 135
###begin article-title 136
Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein.
###end article-title 136
###begin article-title 137
Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo.
###end article-title 137
###begin article-title 138
Results of a high-resolution genome screen of 437 Alzheimer's disease families.
###end article-title 138
###begin article-title 139
A full genome scan for late onset Alzheimer's disease.
###end article-title 139
###begin article-title 140
Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.
###end article-title 140
###begin article-title 141
Confirmation of association between D10S583 and Alzheimer's disease in a case-control sample.
###end article-title 141
###begin article-title 142
Genetic variation in a haplotype block spanning IDE influences Alzheimer disease.
###end article-title 142
###begin article-title 143
Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease.
###end article-title 143
###begin article-title 144
Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
###end article-title 144
###begin article-title 145
Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease.
###end article-title 145
###begin article-title 146
Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE.
###end article-title 146
###begin article-title 147
Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease.
###end article-title 147
###begin article-title 148
Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease.
###end article-title 148
###begin article-title 149
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Insulin degrading enzyme and alpha-3 catenin polymorphisms in Italian patients with Alzheimer disease.
###end article-title 149
###begin article-title 150
Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease.
###end article-title 150
###begin article-title 151
Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE).
###end article-title 151
###begin article-title 152
Mutation screening of a haplotype block around the insulin degrading enzyme gene and association with Alzheimer's disease.
###end article-title 152
###begin article-title 153
Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures.
###end article-title 153
###begin article-title 154
Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.
###end article-title 154
###begin article-title 155
Lack of association of 5 SNPs in the vicinity of the insulin-degrading enzyme (IDE) gene with late-onset Alzheimer's disease.
###end article-title 155
###begin article-title 156
No association between the insulin degrading enzyme gene and Alzheimer's disease in a Japanese population.
###end article-title 156
###begin article-title 157
Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
###end article-title 157
###begin article-title 158
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
###end article-title 158
###begin article-title 159
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.
###end article-title 159
###begin article-title 160
###xml 74 79 <span type="species:ncbi:9606">human</span>
Effects of genome-wide heterozygosity on a range of biomedically relevant human quantitative traits.
###end article-title 160
###begin article-title 161
Genome-wide association study of biochemical traits in Korcula Island, Croatia.
###end article-title 161
###begin article-title 162
###xml 128 133 <span type="species:ncbi:9606">Human</span>
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
###end article-title 162
###begin article-title 163
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 163
###begin article-title 164
Score tests for association between traits and haplotypes when linkage phase is ambiguous.
###end article-title 164
###begin article-title 165
PLINK: a tool set for whole-genome association and population-based linkage analyses.
###end article-title 165
###begin article-title 166
Case-control studies of genetic markers: power and sample size approximations for Armitage's test for trend.
###end article-title 166
###begin article-title 167
An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.
###end article-title 167
###begin article-title 168
Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.
###end article-title 168
###begin article-title 169
GenABEL: an R library for genome-wide association analysis.
###end article-title 169
###begin p 170
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 170
###begin p 171
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 252 256 <span type="species:ncbi:162683">Mayo</span>
###xml 348 352 <span type="species:ncbi:162683">Mayo</span>
###xml 373 380 <span type="species:ncbi:9606">Patient</span>
Funding: This work was supported by the National Institutes of Health [R01 AG18023 to N.R.G.-R. and S.G.Y., KL2 RR024151 to N.E.-T.]; National Institute on Aging [AG25711, AG17216, AG03949 to D.W.D., U24 AG21886 to N.C.R.A.D., F32 AG20903 to N.E.-T.]; Mayo Alzheimer's Disease Research Center [P50 AG16574 to R.C.P., D.W.D., N.R.G.-R. and S.G.Y.]; Mayo Alzheimer's Disease Patient Registry [U01 AG06576 to R.C.P.]; Robert and Clarice Smith Postdoctoral Fellowship to M.M.C.; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program to R.C.P., D.W.D., N.R.G.-R., S.G.Y.; the Palumbo Professorship in Alzheimer's Disease Research to S.G.Y.; the Johnnie B. Byrd and Siragusa Foundation grants to N.E.-T.; the Medical Research Council UK to H.C., A.F.W. and I.R.; the Ministry of Science, Education and Sports of the Republic of Croatia [108-1080315-0302] and from the European Commission FP6 STRP [018947 LSHG-CT-2006-01947] to I.R., and K.M. holds Network Centre, collaborative and project grants from the Alzheimer's Research Trust. Oxford Project to Investigate Memory and Ageing (OPTIMA) is supported by grants from the Charles Wolfson Charitable Trust, Norman Collisson Foundation, Alzheimer's Research Trust and Merck and Co. Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 171

